Literature DB >> 22098464

Activated lymphocytes and high liver expression of IFN-γ are associated with fulminant hepatic failure in patients.

Damião C M dos Santos1, Patricia C C Neves, Elzinandes L Azeredo, Marcelo Pelajo-Machado, José Manoel S G Martinho, Lúcio F Pacheco-Moreira, Cristina C V Araújo, Oswaldo Gonçalves Cruz, Jaqueline Mendes de Oliveira, Marcelo Alves Pinto.   

Abstract

BACKGROUND & AIMS: To study immunological mechanisms of fulminant hepatic failure (FHF) derived from extensive liver lesions, 14 patients with FHF induced by different aetiologies were investigated by observance of both lymphocyte phenotyping and cytokine levels.
METHODS: Five patients bearing benign acute hepatitis B (AHB) and seven healthy liver donors (HC) were used as controls. Samples of liver and blood from both FHF patients and HC were obtained during transplantation procedures. Plasma levels of IL-1β, IL-4, IL-6, IL-8, IL-10, IFN-γ, TNF-α, MCP-1, RANTES and MIP-1α were quantified using a multiplex immunoassay. Cell characterization was carried out by flow cytometry. IFN-γ staining was performed on liver sections using immunofluorescence methods.
RESULTS: An increase of peripheral frequency of natural killer (NK) cells expressing early activation markers (CD69, HLA-DR and CD38) and adhesion molecule CD44 was observed in FHF patients. Elevated frequency of T lymphocytes CD4(+) and CD8(+) expressing CD38 and adhesion molecules CD29 and CD44 was also observed in FHF. Additionally, an increase of natural killer T cells (NKT) was detected in FHF patients. High plasma cytokine levels were not statistically different between FHF and AHB patients. In comparison to HC, a strong liver expression of IFN-γ was detected in FHF patients. The increased frequency of CD4(+) CD44(+) and IL-8 cytokine was found in patients with poor prognosis.
CONCLUSIONS: These findings indicate the involvement of NK and NKT cells as well as T lymphocytes CD4(+) and CD8(+) in the inflammatory process inducing FHF, confirmed by the high hepatic expression of IFN-γ.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22098464     DOI: 10.1111/j.1478-3231.2011.02654.x

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  9 in total

1.  A Dual Role of Complement Activation in the Development of Fulminant Hepatic Failure Induced by Murine-Beta-Coronavirus Infection.

Authors:  Yingying Fang; Yan Guo; Tongtong Gao; Xuelian Han; Yuting Jiang; Min Li; Wei Xue; Binhui Yang; Yujun Cui; Shihui Sun; Guangyu Zhao
Journal:  Front Cell Infect Microbiol       Date:  2022-04-29       Impact factor: 6.073

2.  Long term expansion of bone marrow-derived hMSCs on novel synthetic microcarriers in xeno-free, defined conditions.

Authors:  Martial Hervy; Jennifer L Weber; Marylene Pecheul; Paula Dolley-Sonneville; David Henry; Yue Zhou; Zara Melkoumian
Journal:  PLoS One       Date:  2014-03-17       Impact factor: 3.240

3.  The effect of citrus peel extracts on cytokines levels and T regulatory cells in acute liver injury.

Authors:  Ia Pantsulaia; Manana Iobadze; Nato Pantsulaia; Tinatin Chikovani
Journal:  Biomed Res Int       Date:  2014-07-13       Impact factor: 3.411

4.  Changes in cellular proliferation and plasma products are associated with liver failure.

Authors:  Juliana Gil Melgaço; Frederico Marianetti Soriani; Pedro Henrique Ferreira Sucupira; Leonardo Assaf Pinheiro; Yasmine Rangel Vieira; Jaqueline Mendes de Oliveira; Lia Laura Lewis-Ximenez; Cristina Carvalho Vianna Araújo; Lúcio Filgueiras Pacheco-Moreira; Gustavo Batista Menezes; Oswaldo Gonçalves Cruz; Claudia Lamarca Vitral; Marcelo Alves Pinto
Journal:  World J Hepatol       Date:  2016-11-18

5.  CD24 aggravates acute liver injury in autoimmune hepatitis by promoting IFN-γ production by CD4+ T cells.

Authors:  Chenhong Zheng; Shulei Yin; Yang Yang; Yizhi Yu; Xiaohua Xie
Journal:  Cell Mol Immunol       Date:  2017-01-09       Impact factor: 11.530

6.  Complement System as a Target for Therapies to Control Liver Regeneration/Damage in Acute Liver Failure Induced by Viral Hepatitis.

Authors:  Juliana Gil Melgaço; Carlos Eduardo Veloso; Lúcio Filgueiras Pacheco-Moreira; Claudia Lamarca Vitral; Marcelo Alves Pinto
Journal:  J Immunol Res       Date:  2018-10-08       Impact factor: 4.818

7.  Increased Circulating T Follicular Helper Cells Induced via IL-12/21 in Patients With Acute on Chronic Hepatitis B Liver Failure.

Authors:  Bingying Du; Jiaming Teng; Rongkun Yin; Yuanyuan Tian; Tingwang Jiang; Yanan Du; Wei Cai
Journal:  Front Immunol       Date:  2021-03-31       Impact factor: 7.561

8.  Risk Factors of Chronic Kidney Disease in Chronic Hepatitis B: A Hospital-based Case-control Study from China.

Authors:  Yunqi Liu; Ximei Wang; Fuping Xu; Dengren Li; Huimin Yang; Nan Sun; Yu-Chen Fan; Xiangdong Yang
Journal:  J Clin Transl Hepatol       Date:  2021-07-23

9.  Assessment of interactions of efavirenz solid drug nanoparticles with human immunological and haematological systems.

Authors:  Neill J Liptrott; Marco Giardiello; Tom O McDonald; Steve P Rannard; Andrew Owen
Journal:  J Nanobiotechnology       Date:  2018-03-15       Impact factor: 10.435

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.